Home Cart Sign in  
Chemical Structure| 1423-26-3 Chemical Structure| 1423-26-3

Structure of 1423-26-3

Chemical Structure| 1423-26-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 1423-26-3 ]

CAS No. :1423-26-3
Formula : C7H6BF3O2
M.W : 189.93
SMILES Code : FC(C1=CC(B(O)O)=CC=C1)(F)F
MDL No. :MFCD00151854
InChI Key :WOAORAPRPVIATR-UHFFFAOYSA-N
Pubchem ID :2734388

Safety of [ 1423-26-3 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Computational Chemistry of [ 1423-26-3 ] Show Less

Physicochemical Properties

Num. heavy atoms 13
Num. arom. heavy atoms 6
Fraction Csp3 0.14
Num. rotatable bonds 2
Num. H-bond acceptors 5.0
Num. H-bond donors 2.0
Molar Refractivity 41.27
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

40.46 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

0.0
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

1.71
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

1.54
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

1.37
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

0.29
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.98

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-2.3
Solubility 0.942 mg/ml ; 0.00496 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-2.18
Solubility 1.27 mg/ml ; 0.00668 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-2.18
Solubility 1.26 mg/ml ; 0.00665 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.24 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

1.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.72

Application In Synthesis of [ 1423-26-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1423-26-3 ]

[ 1423-26-3 ] Synthesis Path-Downstream   1~16

  • 1
  • [ 1423-26-3 ]
  • [ 342777-09-7 ]
  • [ 939-57-1 ]
  • (E)-3-[2-(3-Trifluoromethyl-benzyl)-phenyl]-acrylic acid [ No CAS ]
  • 2
  • [ 29022-11-5 ]
  • [ 1423-26-3 ]
  • [ 210282-31-8 ]
  • 2-(2-carboxy-ethyl)-[1,3]oxazinane-3-carboxylic acid <i>tert</i>-butyl ester [ No CAS ]
  • [(5S,10bR)-3-Oxo-8-(3-trifluoromethyl-phenyl)-1,2,3,5,6,10b-hexahydro-pyrrolo[2,1-a]isoquinoline-5-carbonyl]-amino}-acetic acid [ No CAS ]
  • 3
  • [ 29022-11-5 ]
  • [ 1423-26-3 ]
  • [ 210282-31-8 ]
  • 2-(2-carboxy-ethyl)-[1,3]oxazinane-3-carboxylic acid <i>tert</i>-butyl ester [ No CAS ]
  • 2-{2-[1-(carboxymethyl-carbamoyl)-2-(3'-trifluoromethyl-biphenyl-3-yl)-ethylcarbamoyl]-ethyl}-[1,3]oxazinane-3-carboxylic acid <i>tert</i>-butyl ester [ No CAS ]
  • 4
  • [ 76-09-5 ]
  • [ 1423-26-3 ]
  • [ 325142-82-3 ]
YieldReaction ConditionsOperation in experiment
47% In toluene; at 20℃; for 2h; The title compound (47%, oil) was prepared from 3-trifluoromethylphenylboronic acid and pinacol. 1H NMR (300 MHz, CDCl3): delta 1.35 (s, 12H), 7.48 (t, 1H), 7.70 (d, 1H), 7.97 (d, 1H), 8.06 (bs, 1H).
  • 5
  • [ 35265-82-8 ]
  • [ 1423-26-3 ]
  • 2-chloro-6-methyl-4-[3-(trifluoromethyl)phenyl]thieno[3,2-d]pyrimidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
89% With sodium carbonate;tetrakis(triphenylphosphine) palladium(0); In water; toluene; for 2.0h;Heating / reflux; To a toluene (10 mL)-water (1 mL) mixed solution of <strong>[35265-82-8]2,4-dichloro-6-methylthieno[3,2-d]pyrimidine</strong> (1.00 g, 4.56 mmol) were added 3-(trifluoromethyl)benzeneboronic acid (0.87 g, 4.56 mmol), sodium carbonate (0.97 g, 9.13 mmol), and tetrakis(triphenylphosphine)palladium (0.10 g, 5 mol%), followed by heating under reflux under a nitrogen stream for 2 hours. After completion of the reaction, the reaction liquid was poured into water and extracted with ethyl acetate. The resulting extract solution was washed with water and brine and then the solvent was removed by evaporation. The residue was purified on a silica gel column (Kiesel gel 60 manufactured by MERCK, 10% AcOEt-Hex) to obtain 2-chloro-6-methyl-4-[3-(trifluoromethyl)phenyl]thieno[3,2-d]pyrimidine (1.33 g, 89%). 1H-NMR (400MHz, CDCl3): 2.75(d, 3H, J=1.2Hz), 7.26(d, 1H, J=1.2Hz), 7.72(t, 1H, J=8.0Hz), 7.85(d, 1H, J=8.0Hz), 8.36(d, 1H, J=8.0Hz), 8.43(s, 1H). mp: 174-176C (dec.)
  • 6
  • [ 1005-38-5 ]
  • [ 1423-26-3 ]
  • [ 932046-86-1 ]
YieldReaction ConditionsOperation in experiment
With potassium carbonate;tetrakis(triphenylphosphine) palladium(0); In toluene; for 10h;Heating / reflux;Product distribution / selectivity; Example 11: 4-(3,3,4-Trimethyl-4-oxy-piperazin-1-yl)-6-(3-trifluoromethyl-phenyl)- pyrimidine-2-carbonitrile A: 2-Methylsulfanyl-6-(3-trifluoromethylphenyl)-pyrimidin-4-ylamine To a stirred solution of <strong>[1005-38-5]4-amino-6-chloro-2-methylthiopyrimidine</strong> (3.5 g) in toluene (45 ml.) under a nitrogen atmosphere was added, sequentially, 3-(trifluoro- methyl)phenylboronic acid (4.15 g), potassium carbonate (25 ml_, 2M) and tetrakis- (triphenylphosphine)palladium(O) (1.16 g). The mixture was heated to reflux for ten hours. Ethyl acetate (15OmL) was added and the mixture washed with water (2 x 100 ml_). Organic layer was separated, washed with saturated sodium chloride (100 ml_), dried over sodium sulphate and solvent was evaporated under reduced pressure to yield crude product. Purification by flash chromatography yielded product 2-methyl- sulfanyl-6-(3-trifluoromethyl-phenyl)-pyrimidin-4-ylamine (3.45 g) 1H NMR (CDCI3): delta 8.25 (s, 1 H), 8.19 (d, 1 H), 7.70 (d, 1 H), 7.58 (t, 1 H), 6.56 (s, 1 H), 4.92 (s, 2H), 2.61 (s, 3H). MS m/z: 286.3 (M+1 ).
With potassium carbonate;tetrakis(triphenylphosphine) palladium(0); In water; toluene; at 20℃;Heating / reflux;Product distribution / selectivity; To a stirred solution of <strong>[1005-38-5]4-amino-6-chloro-2-methylthiopyrimidine</strong> (3.5 g) in toluene (45 mL) under a nitrogen atmosphere was added, sequentially, 3-(trifluoromethyl)phenylboronic acid (4.15 g), potassium carbonate (25 mL, 2M) and tetrakis(triphenylphosphine)palladium(0) (1.16 g). The mixture was heated to reflux for ten hours. Ethyl acetate (150 mL) was added and the mixture washed with water (2.x.100 mL). Organic layer was separated, washed with saturated sodium chloride (100 mL), dried over sodium sulphate and solvent was evaporated under reduced pressure to yield crude product. Purification by flash chromatography yielded product 2-methylsulfanyl-6-(3-trifluoromethyl-phenyl)-pyrimidin-4-ylamine (3.45 g) 1H NMR (CDCl3): delta 8.25 (s, 1H), 8.19 (d, 1H), 7.70 (d, 1H), 7.58 (t, 1H), 6.56 (s, 1H), 4.92 (s, 2H), 2.61 (s, 3H). MS m/z: 286.3 (M+1).; A: 2-Methylsulfanyl-6-(3-trifluoromethylphenyl)-pyrimidin-4-ylamine To a stirred solution of <strong>[1005-38-5]4-amino-6-chloro-2-methylthiopyrimidine</strong> (3.5 g) in toluene (45 mL) under a nitrogen atmosphere was added, sequentially, (3-trifluoromethylphenyl)boronic acid (4.15 g), potassium carbonate (25 mL, 2M) and tetrakis(triphenylphosphine)palladium(0) (1.16 g). The mixture was heated to reflux for ten hours and stirred at room temperature over the weekend. Ethyl acetate (150 mL) was added and the mixture washed with water (2.x.100 mL). Organics were separated, washed with saturated sodium chloride (100 mL), dried over sodium sulphate and solvent was evaporated under reduced pressure to yield crude product. Purification by flash chromatography yielded product 2-methylsulfanyl-6-(3-trifluoromethyl-phenyl)-pyrimidin-4-ylamine (3.45 g) 1H NMR (CDCl3): 8.25 (s, 1H), 8.19 (d, 1H), 7.70 (d, 1H), 7.58 (t, 1H), 6.56 (s, 1H), 4.92 (s, 2H), 2.61 (s, 3H). MS m/z 286.3 (M+1).
  • 7
  • [ 363-52-0 ]
  • [ 1423-26-3 ]
  • [ 402564-35-6 ]
  • 8
  • [ 959992-62-2 ]
  • [ 1423-26-3 ]
  • [ 1303587-79-2 ]
YieldReaction ConditionsOperation in experiment
With caesium carbonate;tetrakis(triphenylphosphine) palladium(0); In 1,4-dioxane; water; at 50℃; 6-bromo-3,4-dihydro-2H-pyrido[3,2-b] [l ,4]oxazine (5; 2.0 g, 9.30 mmol), 3-(trifluromethyl)- phenylboronic acid (2.65 g, 1 3.95 mmol), Pd(Ph3)4 (21 5 mg, 0. 186 mmol) and CsCO3 (6.0 g, 18.6 mmol) were all dissolved in dioxane:H20 mixture (45 mL: l mL) and heated to 50 C overnight. Product peak seen by LCMS, but some starting material remained, added more boronic acid and stirred at 50 C overnight. The starting material peak was unchanged, cooled to room temp and some precipitates started to crash out. Diluted with water (40 mL), extracted with EtOAc (3 x 40 mL), washed with brine, dried over MgS04, filtered, concentrated and purified through I SCO silica column (0 to 100% EtOAc/pentanes) to collect mixed fractions of 6-(3-(trifluoromethyl)phenyl)-3,4-dihydro-2H-pyrido[3,2-b][ l ,4]oxazine (6) M S (ESI) calcd for C 14H1 1 F3N2O (m/z) 280.08, found 281 [M+H].
  • 9
  • [ 1303587-99-6 ]
  • [ 1423-26-3 ]
  • [ 1303588-00-2 ]
YieldReaction ConditionsOperation in experiment
52% With sodium carbonate;tetrakis(triphenylphosphine) palladium(0); In 1,4-dioxane; water; at 120℃; for 12h;Inert atmosphere; sealed tube; 2-Chloro-7,8-dihydro-6H-pyrimido[5,4-b][l,4]oxazine (68; 1.41 g, 8.22 mmol), 3- (trifluoromethyl)phenylboronic acid (1.87 g, 9.86 mmol), Pd(PPh3)4 (475 mg, 0.411 mmol), Na2C03 (2.09 g, 19.7 mmol) and dioxane/water(4:l, 35 ml) were added to a sealed tube and filled with nitrogen. Then the mixture was heated to 120 C for 12 hours. After cooling, CH2CI2 (100 mL) was added and the mixture was passed through a pad of Na2SO
  • 10
  • [ 586-77-6 ]
  • [ 1423-26-3 ]
  • [ 63744-25-2 ]
  • [ 1412908-98-5 ]
  • 12
  • [ 1060812-84-1 ]
  • [ 1423-26-3 ]
  • C14H9F3N2 [ No CAS ]
  • 13
  • [ 52133-67-2 ]
  • [ 1423-26-3 ]
  • ethyl 2-(3-(trifluoromethyl)phenyl)-1H-pyrrole-3-carboxylate [ No CAS ]
  • 14
  • [ 120157-97-3 ]
  • [ 1423-26-3 ]
  • 2-(3'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)ethan-1-amine hydrochloride [ No CAS ]
YieldReaction ConditionsOperation in experiment
56% General procedure: A mixture of N-boc-2-(4-bromophenyl)ethylamine, the desiredarylboronic acid (a-m) (1.2 equiv), tetrakis(triphenylphosphine)-palladium(0) (0.04 equiv), Na2CO3 (5 equiv) in degassed toluene/H2O (5/2) was refluxed for 18 h. The reaction mixture was filteredthrough Celite and concentrated in vacuo. The resulting residuewas dissolved in in EtOAc (200 mL), washed with H2O (200 mL 2) and brine (200 mL). The organic layer was dried with anhydrousNa2SO4 and concentrated in vacuo. The residue was purified by columnchromatography on SiO2.Using Method E, 13 (1.00?g, 3.3?mmol), 3-(trifluoromethyl)phenylboronic acid (0.76?g, 4.0?mmol), tetrakis(triphenylphosphine)palladium(0) (0.15?g, 0.1?mmol), Na2CO3 (1.77?g, 16.7?mmol) in toluene/H2O (33?ml/13.3?ml), followed by 4.0?M HCl in dioxane (2.50?ml, 10.0?mmol) gave 14a as a white solid (0.57?g, 56%): Rf?=?0.00 (EtOAc 9: acetone 1): 1H NMR (DMSO-d6, 400?MHz) delta 2.98-3.10 (m, NH3CH2CH2), 7.42 (d, J?=?8.2?Hz, 2 ArH), 7.69-7.74 (m, 4 ArH), 7.95-8.00 (m, 2 ArH), 8.31 (s, NH3); 13C NMR (DMSO-d6, 100?MHz) delta 33.0 (NCH2CH2), 123.4 (q, JC-F?=?3.9?Hz), 124.4 (q, JC-F?=?3.7?Hz), 124.7 (CF3, q, JC-F?=?270.9?Hz), 127.6, 129.9, 130.2 (q, JC-F?=?31.4?Hz), 130.5, 131.1, 137.4, 138.1, 141.4 (12 ArC).
  • 15
  • [ 1001070-33-2 ]
  • [ 1423-26-3 ]
  • 1-(phenylsulfonyl)-5-(3-[trifluoromethyl]phenyl)-1H-pyrrolo[2,3-b]pyridine [ No CAS ]
  • 16
  • [ 1423-26-3 ]
  • [ 591-19-5 ]
  • [ 400749-02-2 ]
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 1423-26-3 ]

Fluorinated Building Blocks

Chemical Structure| 128796-39-4

A104094 [128796-39-4]

(4-(Trifluoromethyl)phenyl)boronic acid

Similarity: 1.00

Chemical Structure| 73852-19-4

A200674 [73852-19-4]

(3,5-Bis(trifluoromethyl)phenyl)boronic acid

Similarity: 0.98

Chemical Structure| 1423-27-4

A144870 [1423-27-4]

(2-Trifluoromethyl)phenylboronic acid

Similarity: 0.96

Chemical Structure| 864759-67-1

A319925 [864759-67-1]

(3-Methyl-4-(trifluoromethyl)phenyl)boronic acid

Similarity: 0.96

Chemical Structure| 947533-94-0

A375037 [947533-94-0]

(4-Methyl-3-(trifluoromethyl)phenyl)boronic acid

Similarity: 0.96

Organoborons

Chemical Structure| 128796-39-4

A104094 [128796-39-4]

(4-(Trifluoromethyl)phenyl)boronic acid

Similarity: 1.00

Chemical Structure| 73852-19-4

A200674 [73852-19-4]

(3,5-Bis(trifluoromethyl)phenyl)boronic acid

Similarity: 0.98

Chemical Structure| 1423-27-4

A144870 [1423-27-4]

(2-Trifluoromethyl)phenylboronic acid

Similarity: 0.96

Chemical Structure| 864759-67-1

A319925 [864759-67-1]

(3-Methyl-4-(trifluoromethyl)phenyl)boronic acid

Similarity: 0.96

Chemical Structure| 947533-94-0

A375037 [947533-94-0]

(4-Methyl-3-(trifluoromethyl)phenyl)boronic acid

Similarity: 0.96

Aryls

Chemical Structure| 128796-39-4

A104094 [128796-39-4]

(4-(Trifluoromethyl)phenyl)boronic acid

Similarity: 1.00

Chemical Structure| 73852-19-4

A200674 [73852-19-4]

(3,5-Bis(trifluoromethyl)phenyl)boronic acid

Similarity: 0.98

Chemical Structure| 1423-27-4

A144870 [1423-27-4]

(2-Trifluoromethyl)phenylboronic acid

Similarity: 0.96

Chemical Structure| 864759-67-1

A319925 [864759-67-1]

(3-Methyl-4-(trifluoromethyl)phenyl)boronic acid

Similarity: 0.96

Chemical Structure| 947533-94-0

A375037 [947533-94-0]

(4-Methyl-3-(trifluoromethyl)phenyl)boronic acid

Similarity: 0.96

Trifluoromethyls

Chemical Structure| 128796-39-4

A104094 [128796-39-4]

(4-(Trifluoromethyl)phenyl)boronic acid

Similarity: 1.00

Chemical Structure| 73852-19-4

A200674 [73852-19-4]

(3,5-Bis(trifluoromethyl)phenyl)boronic acid

Similarity: 0.98

Chemical Structure| 1423-27-4

A144870 [1423-27-4]

(2-Trifluoromethyl)phenylboronic acid

Similarity: 0.96

Chemical Structure| 864759-67-1

A319925 [864759-67-1]

(3-Methyl-4-(trifluoromethyl)phenyl)boronic acid

Similarity: 0.96

Chemical Structure| 947533-94-0

A375037 [947533-94-0]

(4-Methyl-3-(trifluoromethyl)phenyl)boronic acid

Similarity: 0.96